Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|September 30, 2006
Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell lineJason Zastre, Malathi Anantha, Euan Ramsay, et al.Molecular Cancer Therapeutics|July 29, 2003
Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosisYanping Hu, Marcel Bally, Wieslawa H Dragowska, et al.Pharmaceutical Research|December 25, 2010
The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™Nilesh Patankar, Malathi Anantha, Euan Ramsay, et al.International Journal of Molecular Sciences|July 2, 2021
Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer ModelJessica Kalra, Jennifer Baker, Justin Song, et al.International Journal of Molecular Sciences|July 15, 2020
Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in LiposomesGabriel Charest, Thititip Tippayamontri, Minghan Shi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cellsYanPing Hu, Awtar Krishan, WeiJia Nie, et al.Journal of Pharmaceutical Sciences|November 8, 2012
Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor modelEmmanuel A Ho, Maryam Osooly, Dita Strutt, et al.Pharmaceutics|September 28, 2021
Gold-Protein Composite Nanoparticles for Enhanced X-ray Interactions: A Potential Formulation for Triggered ReleaseCourtney van Ballegooie, Alice Man, Alessia Pallaoro, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 2, 2007
A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retentionEuan Ramsay, Jehan Alnajim, Malathi Anantha, et al.Pharmaceutical Research|October 26, 2006
Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformationEuan Ramsay, Jehan Alnajim, Malathi Anantha, et al.Pageof 3